Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107284
Filing Date
2025-08-12
Accepted
2025-08-12 16:05:21
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vivs-20250630.htm   iXBRL 10-Q 1709082
2 EX-31.1 vivs-ex31_1.htm EX-31.1 13842
3 EX-31.2 vivs-ex31_2.htm EX-31.2 13810
4 EX-32.1 vivs-ex32_1.htm EX-32.1 11462
  Complete submission text file 0000950170-25-107284.txt   7013206

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20250630.xsd EX-101.SCH 1165693
62 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20250630_htm.xml XML 954162
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 251206600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)